Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000089725

Apexbio Technology LLC Bromocriptine mesylate 22260-51-1 10mM (in 1mL DMSO)
SDP

Catalog No. 5000089725
Encompass_Preferred

Bromocriptine mesylate (CAS 22260-51-1) is a selective agonist of D -like dopamine receptors exhibiting high affinity with a pKi of 8 05 0 2 Through modulation of D receptor activity bromocriptine mesylate influences metabolic processes by reducing glucose intolerance and insulin resistance inhibits pituitary prolactin secretion and enhances motor function relevant to Parkinson s disease The compound has established applications in research on metabolic disorders neuroendocrine regulation and neurodegenerative diseases including studies pertaining to type 2 diabetes prolactinomas acromegaly and Parkinson s disease

Catalog No. 50-000-89725 Supplier Apexbio Technology LLC Supplier No. B62985.1
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bromocriptine mesylate (CAS 22260-51-1) is a selective agonist of D -like dopamine receptors exhibiting high affinity with a pKi of 8 05 0 2 Through modulation of D receptor activity bromocriptine mesylate influences metabolic processes by reducing glucose intolerance and insulin resistance inhibits pituitary prolactin secretion and enhances motor function relevant to Parkinson s disease The compound has established applications in research on metabolic disorders neuroendocrine regulation and neurodegenerative diseases including studies pertaining to type 2 diabetes prolactinomas acromegaly and Parkinson s disease

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.